Patents Assigned to MAYNE PHARMA LLC
  • Corticosteroid containing foam compositions and method of manufacture thereof
    Patent number: 11020407
    Abstract: The present invention provides a method for treating various skin diseases by topically administering to a subject a composition formulated as a foamable composition which includes a corticosteroid, such as halobetasol. The composition may include a corticosteroid, ethyl alcohol, emulsifying wax, cetostearyl alcohol, polyoxyl 20 cetostearyl ether, water, benzoic acid and propellant.
    Type: Grant
    Filed: November 30, 2016
    Date of Patent: June 1, 2021
    Assignee: MAYNE PHARMA LLC
    Inventors: Robert T. Gauthier, James D. Hammer
  • Halobetasol foam composition and method of use thereof
    Patent number: 10857159
    Abstract: The present invention provides a composition and method for treating various skin diseases. The composition is formulated as a foamable composition and includes the corticosteroid halobetasol.
    Type: Grant
    Filed: November 30, 2016
    Date of Patent: December 8, 2020
    Assignee: MAYNE PHARMA LLC
    Inventors: Robert T. Gauthier, James D. Hammer
  • Topical foam composition
    Patent number: 10688071
    Abstract: The present invention relates to a novel oil in water emulsion aerosol foam composition containing an active agent for the treatment of various chronic and acute skin conditions, particularly acne and psoriasis; and processes for preparing the emulsion aerosol foam compositions. In particular, the present invention relates to oil in water emulsion aerosol foam compositions containing a retinoid in the oil phase.
    Type: Grant
    Filed: July 19, 2012
    Date of Patent: June 23, 2020
    Assignee: MAYNE PHARMA LLC
    Inventor: Leon Loupenok
  • Topical foam composition
    Patent number: 10568859
    Abstract: The present invention relates to a novel oil in water emulsion aerosol foam composition containing an active agent for the treatment of various chronic and acute skin conditions, particularly acne and psoriasis; and processes for preparing the emulsion aerosol foam compositions. In particular, the present invention relates to oil in water emulsion aerosol foam compositions containing a retinoid in the oil phase.
    Type: Grant
    Filed: February 24, 2010
    Date of Patent: February 25, 2020
    Assignee: MAYNE PHARMA LLC
    Inventor: Leon Loupenok